Bratislav Kircanski

Bratislav Kircanski

Auto-generated profile, based on publicly available information

Bratislav Kircanski

University Clinical Center of Serbia, Pacemaker Center, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in EP Europace
Verified
Journal Article
Open access
PDF file
BKBratislav Kircanski
Bratislav Kircanski
SBSerge Boveda
Serge Boveda
FPF.W. W. Prinzen
F.W. W. Prinzen
ASAntonio Sorgente
Antonio Sorgente
AAAnte Anic
Ante Anic
HBHaran Burri
Haran Burri
With the increasing interest in conduction system pacing (CSP) over the last few years and the inclusion of this treatment modality in the current guidelines, our aim was to provide a snapshot of current practice across Europe. An online questionnaire was sent to physicians participating in the European Heart Rhythm Association research network as well as to national societies and over social media. Data on previous experience with CSP, current indications, preferred tools, unmet needs, and perceptions for the future are reported and discussed.

1 April 2016 in Journal of Medical Biochemistry
Verified
Journal Article
Open access
PDF file
IPIgor Petrović
Igor Petrović
ISIvan Stankovic
Ivan Stankovic
GMGoran Milasinovic
Goran Milasinovic
GNGabrijela Nikcevic
Gabrijela Nikcevic
BKBratislav Kircanski
Bratislav Kircanski
SPSinisa U. Pavlovic
Sinisa U. Pavlovic
Summary: Background:In the majority of patients with a wide QRS complex and heart failure resistant to optimal medical therapy, cardiac resynchronization therapy (CRT) leads to rever se ventricular remodeling and possibly to changes in cardiac collagen synthesis and degradation. We investigated the relationship of biomarkers of myocardial collagen meta bolism and volumetric response to CRT.Methods:We prospectively studied 46 heart failure patients (mean age 61±9 years, 87% male) who underwent CRT im plantation. Plasma concentrations of amino-terminal pro peptide type I (PINP), a marker of collagen synthesis, and carboxy-terminal collagen telopeptide (CITP), a marker of collagen degradation, were measured before and 6 months after CRT. Response to CRT was defined as 15% or greater reduction in left ventricular end-systolic volume at 6-month follow-up.Results:Baseline PINP levels showed a negative correlation with both left ventricular end-diastolic volume (r=−0.51; p=0.032), and end-systolic diameter (r=−0.47; p=0.049). After 6 months of device implantation, 28 patients (61%) responded to CRT. No significant differences in the base-line levels of PINP and CITP between responders and nonresponders were observed (p>0.05 for both). During follow-up, responders demonstrated a significant increase in serum PINP level from 31.37±18.40 to 39.2±19.19 μg/L (p=0.049), whereas in non-responders serum PINP levels did not significantly change (from 28.12±21.55 to 34.47±18.64 μg/L; p=0.125). There were no significant changes in CITP levels in both responders and non-responders (p>0.05).Conclusions:Left ventricular reverse remodeling induced by CRT is associated with an increased collagen synthesis in the first 6 months of CRT implantation.

1 January 2024 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
NBNemanja S. Branković
Nemanja S. Branković
NRNikola Radovanovic
Nikola Radovanovic
BKBratislav Kircanski
Bratislav Kircanski
SPSiniša U. Pavlović
Siniša U. Pavlović
NVNikola Vujadinovic
Nikola Vujadinovic
GMGoran Milasinovic
Goran Milasinovic
Introduction/Objective. Persistent left superior vena cava (PLSVC) is the most common congenital malformation of the thoracic venous system and may often complicate cardiac implantable electronic device (CIED) lead implantation. The purpose of this study was to assess feasibility and safety of CIED lead implantation through PLSVC and its long-term efficacy. Methods. This is a retrospective observational study performed in a tertiary center from July 2005 to July 2019 among patients with fully successful implantation of all intended CIED leads through PLSVC. Results. CIED implantation was successfully completed with left-side approach in 26 of 32 (81.3%) patients with PLSVC. The average implantation time was 62, 73.5, 120, 74, 103.3, and 130 minutes and the average fluoroscopy time was 13.3, 20.8, 35.7, 17.1, 45.6, and 42.6 minutes for single and dual-chamber pacemakers, ICD-VR, ICD-DR, CRT-P, and CRT-D devices, respectively. The average follow-up period was 43.5 ? 29.9 months. During the follow-up period no CIED leads-related complications were noticed. Conclusion. The results of our study showed that the presence of PLSVC is not an obstacle for CIED implantation. The long-term follow-up proved stability of CIED leads implanted through PLSVC.